However, based on the reported average levels of IFN-γ and IL-17, our estimation of the Th1/Th17 ratio would suggest a slight shift from Th1 to Th17 comparing CIS to RRMS and to SPMS. This evidence concerns the gene IL17A and in situ carcinoma.